: Tentative guidance for certain potential agents, as seen in the CLSI AST Newsletter . Current Edition and Availability
: Vibrio species and Campylobacter jejuni/coli .
: "Breakpoints" (susceptible, intermediate, or resistant) tailored to the unique growth characteristics of these bacteria. clsi document m45 pdf
Clinical microbiology laboratories frequently encounter common pathogens like E. coli or Staphylococcus aureus , which are well-documented in standard AST protocols. However, or fastidious bacteria—which have complex nutritional requirements or occur rarely in clinical specimens—require modified testing conditions. The M45 document provides:
The guideline is indispensable for testing a diverse range of pathogens, including but not limited to: : Tentative guidance for certain potential agents, as
: Specialized advice on drug selection, incubation environments (e.g., increased CO2cap C cap O sub 2 ), and quality control (QC) procedures. Organisms Covered in CLSI M45
: Abiotrophia and Granulicatella species (nutritionally variant streptococci), Aeromonas species, Pasteurella species, and the HACEK group (e.g., Aggregatibacter , Cardiobacterium ). The M45 document provides: The guideline is indispensable
: Detailed instructions for performing broth microdilution and agar disk diffusion for specific "non-standard" organisms.
: Listeria monocytogenes , Corynebacterium species, Bacillus species (excluding B. anthracis ), and Erysipelothrix rhusiopathiae .
The document, titled Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria , is a specialized guideline developed by the Clinical and Laboratory Standards Institute (CLSI) . It serves as a critical extension to the primary antimicrobial susceptibility testing (AST) standards, specifically covering organisms that are not included in the more common CLSI M100 supplement. Core Purpose and Scope

Out of stock